Metraipolis › archive › dc_c12d781fa77f

Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human — Europe PMC PMID:40784919

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40784919
DOI: 10.1007/s00213-[numero omesso]-4
License (as archived): solo-consultazione
Archived: 2026-11-10T17:47:48.094Z
SHA-256 of the archived text: 1b41efc8a1bad9f68220f952f828e4e11e62ae974ccd61aad967145c1e0fe487
Stable URL of this page: https://metraipolis.com/documento/dc_c12d781fa77f

How to cite

Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human — Europe PMC PMID:40784919 — Europe PMC (en), https://europepmc.org/article/MED/40784919 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c12d781fa77f (Metraipolis archive dc_c12d781fa77f, sha256 1b41efc8a1bad9f68220f952f828e4e11e62ae974ccd61aad967145c1e0fe487)

BibTeX

@misc{dcc12d781fa77f,
  title = {Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human — Europe PMC PMID:40784919},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40784919},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c12d781fa77f; sha256 1b41efc8a1bad9f68220f952f828e4e11e62ae974ccd61aad967145c1e0fe487},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40784919. Agents can read the archived copy with the MCP tool read_document.